For the year ending 2025-12-31, EMMA has $21,436K in assets. $85,044K in debts. $2,127K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 2,127 | |||
| Accounts receivable, net | 2,804 | |||
| Inventories, net | 1,555 | |||
| Prepaid expenses and other current assets | 1,260 | |||
| Total current assets | 7,746 | |||
| Property and equipment, gross | 469 | |||
| Less accumulated depreciation | 356 | |||
| Property and equipment, net | 113 | |||
| Right of use assets | 766 | |||
| Investment in convertible bond | 12,604 | |||
| Other assets | 207 | |||
| Total assets | 21,436 | |||
| Accounts payable and accrued expenses | 22,615 | |||
| Operating lease liabilities, current portion | 348 | |||
| Conversion feature derivative, notes payable | 0 | |||
| Other current liabilities | 17,565 | |||
| Warrant derivative liabilities | 13 | |||
| Notes payable, current portion, net of discount-Nonrelated Party | 8,019 | |||
| Notes payable, current portion, net of discount-Related Party | 3,132 | |||
| Convertible notes payable, net of discount | 17,380 | |||
| Total current liabilities | 69,072 | |||
| Operating lease liabilities, less current portion | 1,409 | |||
| Other long-term liabilities | 12,292 | |||
| Notes payable, less current portion, net of discount | 2,271 | |||
| Total liabilities | 85,044 | |||
| Common stock, par value 0.001 per share, 250,000,000 shares authorized, 70,188,263 and 63,865,571 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 70 | |||
| Additional paid-in capital | 225,987 | |||
| Net loan receivable from ej holdings | 16,869 | |||
| Accumulated other comprehensive loss | -2,729 | |||
| Accumulated deficit | -270,067 | |||
| Total stockholders' deficit | -63,608 | |||
| Total liabilities and stockholders' deficit | 21,436 | |||
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)